KUAISHOU-W (01024) granted a total of 9.79433 million restricted share units.

20:11 20/01/2025

-W (01024) announced that on January 20, 2025, the company will issue a certain number of shares to eligible participants in accordance with the...

KUAISHOU-W (01024) announced that on January 20, 2025, the company granted a total of 9.79433 million restricted stock units to eligible participants under the 2023 share incentive plan, but they must be accepted by the grantees before they can become effective.

A-share evening hot spots | Six departments issue heavyweight documents related to promoting consumption

New Stock News | Baoji Pharmaceutical has passed the hearing of the Hong Kong Stock Exchange, and its core product SJ02 has obtained NDA approval from the National Medical Products Administration.

DOWWAY (08403) received an acquisition of controlling stake by Sun Wei and a discount of about 65.75% in cash tender offer. It will resume trading on November 27th.

A-share evening hot spots | Six departments issue heavyweight documents related to promoting consumption

New Stock News | Baoji Pharmaceutical has passed the hearing of the Hong Kong Stock Exchange, and its core product SJ02 has obtained NDA approval from the National Medical Products Administration.

DOWWAY (08403) received an acquisition of controlling stake by Sun Wei and a discount of about 65.75% in cash tender offer. It will resume trading on November 27th.